Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Leyla Roshangar"'
Publikováno v:
Pharmaceutical Sciences, Vol 27, Iss 4, Pp 552-559 (2021)
Background: Acute lymphoblastic leukemia (ALL) is a fetal hematologic disorder that is mostly observed in children. Both B and T lymphocytes have been reported to play a role in ALL etiology. Long non-coding RNAs (lncRNAs) are large regulatory molecu
Externí odkaz:
https://doaj.org/article/da143d311d3b4653ab164991d67c4862
Publikováno v:
Pharmaceutical Sciences, Vol 27, Iss 3, Pp 385-392 (2021)
Background: Childhood acute lymphoblastic leukemia (ALL) explains 26% of pediatricmalignancies and is one of the leading causes of disease-related deaths in children. A novelmolecular class of non-coding genes, long non-coding RNAs (lncRNAs) having o
Externí odkaz:
https://doaj.org/article/84e86a8573304ac0afc2e164f384359c
Publikováno v:
Pharmaceutical Sciences, Vol 27, Iss 4, Pp 552-559 (2021)
Introduction Acute lymphoblastic leukemia (ALL) is a fetal hematologic disorder that is mostly observed in children. Both B and T lymphocytes have been reported to play a role in ALL etiology. Long non-coding RNAs (lncRNAs) are large regulatory molec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f93df7644dec19c2531d353804233d9
https://ps.tbzmed.ac.ir/PDF/ps-27-552.pdf
https://ps.tbzmed.ac.ir/PDF/ps-27-552.pdf
Publikováno v:
Pharmaceutical Sciences, Vol 27, Iss 3, Pp 385-392 (2021)
Background: Childhood acute lymphoblastic leukemia (ALL) explains 26% of pediatricmalignancies and is one of the leading causes of disease-related deaths in children. A novelmolecular class of non-coding genes, long non-coding RNAs (lncRNAs) having o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4c3bd40cda75f717f9720d93208a348
https://doi.org/10.34172/ps.2020.84
https://doi.org/10.34172/ps.2020.84
Autor:
Somayeh Mahdinloo, Salar Hemmati, Hadi Valizadeh, Mohammad Mahmoudian, Javad Mahmoudi, Leyla Roshangar, Muhammad Sarfraz, Parvin Zakeri-Milani
Publikováno v:
International Journal of Pharmaceutics. 625:122063
The development of a therapeutic system for hepatic fibrosis has become a research hotspot to date. Butein, a simple chalcone derivative, displays anti-fibrotic effects through different pathways. However, impurities, low solubility, and low concentr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d9e2785ad7263d6c757c9fe884a3743
https://doi.org/10.1016/j.ijpharm.2022.122063
https://doi.org/10.1016/j.ijpharm.2022.122063